Literature DB >> 17414934

CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater.

Luuk Gras1, Anouk M Kesselring, James T Griffin, Ard I van Sighem, Christophe Fraser, Azra C Ghani, Frank Miedema, Peter Reiss, Joep M A Lange, Frank de Wolf.   

Abstract

OBJECTIVE: CD4 cell count changes in therapy-naive patients were investigated during 7 years of highly active antiretroviral therapy (HAART) in an observational cohort.
METHODS: Three endpoints were studied: (1) time to >or=800 CD4 cells/mm in 5299 therapy-naive patients starting HAART, (2) CD4 cell count changes during 7 years of uninterrupted HAART in a subset of 544 patients, and (3) reaching a plateau in CD4 cell restoration after 5 years of HAART in 366 virologically suppressed patients.
RESULTS: Among patients with <50, 50 to 200, 200 to 350, 350 to 500, and >or=500 CD4 cells/mm at baseline, respectively, 20%, 26%, 46%, 73%, and 87% reached >or=800 CD4 cells/mm within 7 years of starting HAART. Periods with HIV RNA levels >500 copies/mL and age >or=50 years were associated with lesser increases in CD4 cell counts between 6 months and 7 years. Having reached >or=800 CD4 cells/mm at 5 years, age >or=50 years, and >or=1 HIV RNA measurement >1000 copies/mL between 5 and 7 years were associated with a plateau in CD4 cell restoration.
CONCLUSIONS: Restoration to CD4 cell counts >or=800 cells/mm is feasible within 7 years of HAART in most HIV-infected patients starting with >or=350 cells/mm and achieving sufficient suppression of viral replication. Particularly in patients >or=50 years of age, it may be beneficial to start earlier than current guidelines recommend.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17414934     DOI: 10.1097/QAI.0b013e31804d685b

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  68 in total

1.  Childhood sexual abuse and depression in Latino men who have sex with men: Does resilience protect against nonadherence to antiretroviral therapy?

Authors:  John A Sauceda; John S Wiebe; Jane M Simoni
Journal:  J Health Psychol       Date:  2014-08-25

2.  Dynamic Visual Display of Treatment Response in HIV-Infected Adults.

Authors:  Jessie K Edwards; Stephen R Cole; Jeffrey N Martin; Richard Moore; W Christopher Mathews; Mari Kitahata; Joseph J Eron; Michael Saag; Michael J Mugavero
Journal:  Clin Infect Dis       Date:  2015-04-01       Impact factor: 9.079

3.  Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.

Authors:  Colleen F Kelley; Christina M R Kitchen; Peter W Hunt; Benigno Rodriguez; Frederick M Hecht; Mari Kitahata; Heide M Crane; James Willig; Michael Mugavero; Michael Saag; Jeffrey N Martin; Steven G Deeks
Journal:  Clin Infect Dis       Date:  2009-03-15       Impact factor: 9.079

Review 4.  Epidemiological Trends for HIV in Southern Africa: Implications for Reaching the Elimination Targets.

Authors:  Brian G Williams; Eleanor Gouws; Pierre Somse; Mpho Mmelesi; Chibwe Lwamba; Trouble Chikoko; Erika Fazito; Mohamed Turay; Eva Kiwango; Pepukai Chikukwa; Henry Damisoni; Michael Gboun
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

Review 5.  Sex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic review.

Authors:  Jessica L Castilho; Vlada V Melekhin; Timothy R Sterling
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-07       Impact factor: 2.205

6.  How HIV treatment could result in effective prevention.

Authors:  Kartik K Venkatesh; Mark N Lurie; Kenneth H Mayer
Journal:  Future Virol       Date:  2010-07       Impact factor: 1.831

7.  Ageing and long-term CD4 cell count trends in HIV-positive patients with 5 years or more combination antiretroviral therapy experience.

Authors:  S T Wright; K Petoumenos; M Boyd; A Carr; S Downing; C C O'Connor; M Grotowski; M G Law
Journal:  HIV Med       Date:  2012-10-04       Impact factor: 3.180

8.  Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort.

Authors:  Alan R Lifson; Elizabeth M Krantz; Lynn E Eberly; Matthew J Dolan; Vincent C Marconi; Amy C Weintrob; Nancy F Crum-Cianflone; Anuradha Ganesan; Patricia L Grambsch; Brian K Agan
Journal:  AIDS Res Ther       Date:  2011-01-18       Impact factor: 2.250

9.  Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.

Authors:  Yves Levy; Christine Lacabaratz; Laurence Weiss; Jean-Paul Viard; Cecile Goujard; Jean-Daniel Lelièvre; François Boué; Jean-Michel Molina; Christine Rouzioux; Véronique Avettand-Fénoêl; Thérèse Croughs; Stéphanie Beq; Rodolphe Thiébaut; Geneviève Chêne; Michel Morre; Jean-François Delfraissy
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

10.  Changes in the clinical epidemiology of HIV infection in the United States: implications for the clinician.

Authors:  Kate Buchacz; Maria Rangel; Rachel Blacher; John T Brooks
Journal:  Curr Infect Dis Rep       Date:  2009-01       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.